GlassScriptPhysician profile
Matthew C Pflederer
NPI 1659614196
$33,411.53
in general payments reported to CMS, 2019-2025
30 companies · $5,576 in 2025
The $5,576 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2021: $2,140 · 2022: $8,435 · 2023: $5,995 · 2024: $11K · 2025: $5,576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $3,155 · Food and Beverage: $2,642 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,635.00 |
| Travel and Lodging | $3,155.39 |
| Food and Beverage | $2,642.20 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $29,662.49 | 2021-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $1,178.04 | 2022-2025 | Triclip, Mitraclip, Jot Dx |
| Stryker Corporation | $217.62 | 2025 | Artix Mt |
| Novo Nordisk INC | $209.73 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Medtronic Vascular, INC. | $204.23 | 2019 | |
| Pfizer INC. | $196.27 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $177.94 | 2022-2025 | |
| Inari Medical, INC. | $171.35 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $136.41 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.17 | 2022-2024 | Lifevest |
| Livanova USA, INC. | $130.35 | 2023 | Tandemlife |
| Cvrx, INC. | $115.77 | 2022 | |
| Irhythm Technologies, INC. | $92.76 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $84.53 | 2022-2024 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $80.23 | 2022-2024 | Verquvo |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $79.04 | 2023-2025 | Definity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.14 | 2022-2025 | Jardiance |
| Edwards Lifesciences Corporation | $67.07 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Amgen INC. | $63.16 | 2022-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $60.47 | 2021-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $49.41 | 2022-2023 | Optimizer |
| Boston Scientific Corporation | $47.21 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $33.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $28.64 | 2022 | |
| Abbvie INC. | $24.26 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.23 | 2025 | |
| Dexcom, INC. | $23.76 | 2025 | Dexcom G6 Transmitter |
| Optinose US, INC. | $17.39 | 2024 | |
| Atricure, INC. | $15.23 | 2025 | Atriclip Laa Exclusion System |
| Kiniksa Pharmaceuticals, LTD. | $13.48 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Pflederer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.